The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health-related quality of life (HRQoL) for patients with advanced/metastatic urothelial carcinoma (UC) enrolled in KEYNOTE-052 who are potentially platinum ineligible.
 
Rafael Morales-Barrera
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; MSD; Sanofi
Speakers' Bureau - Astellas Pharma; Merck/Pfizer; MSD Oncology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; MSD; Pfizer; Roche/Genentech; Sanofi
 
Daniel E. Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Pfizer; Roche
 
Peter H. O'Donnell
Stock and Other Ownership Interests - allergan
Honoraria - Astellas Pharma; Atheneum; Axiom Healthcare Strategies; CLD, Inc.; Dedham Group; EMD Serono; Genentech/Roche; Health Advances; IntrinsiQ; ISMIE; Janssen; Merck; NAMCP; Pfizer; Seagen
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Janssen (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Janssen; Seattle Genetics/Astellas
Other Relationship - Dragonfly Therapeutics; G1 Therapeutics; Janssen; Nektar; NIH
 
Petros Grivas
Consulting or Advisory Role - 4D Pharma; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Dyania Health; EMD Serono; Exelixis; Genentech; Gilead Sciences; Guardant Health; Infinity Pharmaceuticals; Janssen; Merck; Mirati Therapeutics; Pfizer; QED Therapeutics; Regeneron; Roche; Seagen; Silverback Therapeutics; Urogen pharma
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); QED Therapeutics (Inst)
 
Jacqueline Vuky
Research Funding - Agendia (Inst); Arvinas (Inst); Astellas Pharma (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Deciphera (Inst); Eisai (Inst); Exelixis (Inst); Fortis (Inst); Genentech (Inst); Ignyta (Inst); Incyte (Inst); Innocrin Pharma (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Polyphor (Inst); Rgenix (Inst)
 
Thomas Powles
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche
 
Kylea R. Potvin
Honoraria - Bayer; Janssen
Consulting or Advisory Role - Knight Pharmaceuticals
 
Susanna Y. Cheng
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck
Speakers' Bureau - Pfizer/EMD Serono
 
Eli Rosenbaum
Stock and Other Ownership Interests - Brainsway; Conergent
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; MSD Oncology; Teva
Speakers' Bureau - MSD Oncology
 
Noah M. Hahn
Honoraria - Bladder Cancer Academy; PeerView; PlatformQ Health
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Champions Oncology; CicloMed; Ferring; Genentech/Roche; GlaxoSmithKline; Health Advances; Incyte; Janssen; Merck; Mirati Therapeutics; Pfizer/EMD Serono; Principa Biopharma; Seattle Genetics/Astellas; Taris BioMedical; Trans Med
Research Funding - Acerta Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); HTG Molecular Diagnostics (Inst); Incyte (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Pieris Pharmaceuticals (Inst); Principa Biopharma (Inst); Seattle Genetics/Astellas (Inst)
 
Daniel Keizman
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Pfizer
 
Fausto Roila
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/UCB Japan (Inst); ERYTECH Pharma (Inst); Exelixis (Inst); Janssen (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
 
Jose Luis Perez-Gracia
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Pierre Fabre; Roche; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Eisai; MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Incyte (Inst); Janssen (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Roche
 
Elizabeth R. Plimack
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Aveo; Bristol-Myers Squibb/Medarex; Calithera Biosciences; Calithera Biosciences; Genentech; Infinity Pharmaceuticals; Janssen; MEI Pharma; Merck; Pfizer; Pfizer; Regeneron; Seagen
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)
 
Ronald De Wit
Honoraria - Astellas Pharma; Merck Sharp & Dohme; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Merck Sharp & Dohme; Orion; Sanofi
Research Funding - Bayer (Inst); Sanofi (Inst)
 
Jin Zhi Xu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Kentaro Imai
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Haojie Li
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Josephine M. Norquist
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Joaquim Bellmunt
Stock and Other Ownership Interests - Rainier Therapeutics
Honoraria - UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Pfizer/EMD Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; MSD Oncology; Pfizer